Jacob Bo Lademann

Title: The Innovations of Jacob Bo Lademann

Introduction

Jacob Bo Lademann is a notable inventor based in Copenhagen, Denmark. He has made significant contributions to the field of virology, particularly in the study of the Hepatitis C virus. His innovative work has implications for drug and vaccine development, showcasing his expertise in the area.

Latest Patents

Lademann holds a patent for the invention titled "Hepatitis C virus expressing reporter tagged NS5A protein." This patent involves the development of Hepatitis C reporter viruses that contain Core through NS2 of prototype isolates of all major HCV genotypes. The remaining genes of isolate JFH1 were incorporated by inserting reporter genes in domain III of HCV NS5A. A deletion upstream of the inserted reporter gene sequence provided favorable growth kinetics in Huh7.5 cells for these viruses. These reporter viruses are valuable for high-throughput analysis of drug and vaccine candidates, as well as patient samples. Additionally, Lademann developed J6/JFH1 recombinants with the 5'UTR of genotypes 1-6, which are useful for studying the function of the 5'UTR in a genotype-specific manner.

Career Highlights

Throughout his career, Jacob Bo Lademann has worked with esteemed institutions such as Hvidovre Hospital and Københavns Universitet. His work in these organizations has allowed him to further his research and contribute to advancements in the field of Hepatitis C.

Collaborations

Lademann has collaborated with notable colleagues, including Judith Margarete Gottwein and Troels Kasper Hoyer Scheel. These collaborations have enriched his research and expanded the impact of his innovations.

Conclusion

Jacob Bo Lademann's contributions to the field of virology, particularly through his patent on Hepatitis C reporter viruses, highlight his role as an influential inventor. His work continues to pave the way for advancements in drug and vaccine development.